Skip banner and top navigation
NHLBI Logo and Link
National Heart, Lung, and Blood Institute: People, Science, Health
 HOME  SITE INDEX  CONTACT US
  
 information for researchers
Link to the National Institutes of Health Link to the Department of Health and Human Services
Skip left side navigation and go to content
NHLBI Home
Information for Patients & the Public
Information for Health Professionals
 Information for Researchers

NHLBI-Supported Research

Online Research Resources

Population Studies

Scientific Reports

Technology Transfer
Funding, Training, & Policies
Clinical Trials
Networks & Outreach
News & Events Center
About NHLBI

Agenda

Working Group
on
“Current and Future Directions in
Stem Cell Transplantation for Hemoglobinopathies”

August 10, 2000
8:15 a.m. - 4:00 p.m.

6701 Rockledge Drive, Room 9100-9104
Bethesda, Maryland 20892

 

8:15 - 8:30 a.m. Opening comments
Director, Division of Blood Diseases and Resources, NHLBI
Dr. Barbara Alving
Dr. Helena Mishoe, NHLBI

(Chair)
Dr. John DiPersio
Washington University School of Medicine

8:30 - 9:00
Dr. Mark Walters, Children’s Hospital of Oakland
Bone Marrow Transplantation for Sickle Cell Disease: Results of a Multi-Center Investigation

9:00 - 9:30
Dr. David Rizzieri, Duke University Medical Center
Chimerism Mediated Immunotherapy for Hemoglobinopathies

9:30 - 10:00
Dr. Suzanne Ildstad, University of Louisville
Mixed Chimerism to Treat Sickle Cell Disease in MHC-Disparate Recipients

10:00 - 10:30  Break

10:30 - 11:00
Dr. John Barrett,  National Heart, Lung, and Blood Institute
Non-myeloablative Transplants - Efficacy and Side Effects
Dr. John Tisdale, National Institute of Diabetes and Digestive and Kidney Diseases, NIH

11:00 -11:30
Dr. John Wagner, University of Minnesota
Transplantation of Children and Adults with Hemoglobinopathies

11:30 - Noon
Dr. Nancy Geller, National Heart, lung, and Blood Institute
Potential Novel Trial Designs for Stem Cell Transplantation

Noon - 12:30 P.M.
Dr. David Kodish, Rainbow Babies & Children’s Hospital
Ethical Issues in Stem Cell Transplantation
for Hemoglobinopathies

12:30 - 2:00   LUNCH (working lunch in small groups)
 

Toward Best Practices/Discussion Topics (Full Working Group)

2:00 - 3:30

 •  Patient Selection Criteria
    Dr. Kwaku Ohene-Frempong, Children’s Hospital of Philadelphia
    Dr. Lennette Benjamin, Albert Einstein College of Medicine
    Dr. Orah Platt , Children’s Hospital Medical Center

 •  Timing of Transplants
    Dr. Blanche Alter, Johns Hopkins School of Public Health Service
    Dr. Jeanne Smith, Columbia University
    Dr. Griffin Rodgers, National Institute of Diabetes and Digestive and Kidney Diseases

 • Preparative Regimens
    Dr. Barrett, National Heart, Lung, and Blood Institute
    Dr. Rizzieri, Duke University Medical Center

 • Transplant Associated Risks
    Dr. Suzanne Ildstad, University of Louisville
    Dr. Mark Walters, Children’s Hospital of Oakland

 •  Alternative Stem Cell Sources
    Dr. John Wagner, University of Minnesota
    Dr. John DiPersio, Washington University School of Medicine
    Dr. John Tisdale, National Institute of Diabetes and Digestive and  Kidney Diseases

 •  Patient/Parent Perspectives
    Dr. Alan Cohen, Children’s Hospital of Philadelphia
    Dr. David Kodish, Rainbow Babies & Children’s Hospital
    (Parent and/or Patient)

3:30 - 4:00
Open Discussion/Summation
Dr. DiPersio, Washington University School of Medicine

4:00    Adjournment

Skip footer links and go to content

HOME · SEARCH · ACCESSIBILITY · SITE INDEX · OTHER SITES · PRIVACY STATEMENT · FOIA · CONTACT US